Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Ups Reduce Radiation Exposure

This article was originally published in Start Up

Executive Summary

The use of cancer radiation therapy and interventional fluoroscopy is expanding rapidly, and start-ups are pioneering innovative technologies to capitalize on the industry-wide movement to reduce radiation exposure and improve outcomes. Profiles of ControlRad Systems, Nanovi, and SoniTrack Systems.

You may also be interested in...



ControlRad Systems Inc.

Cancer-causing radiation exposure isn't just a concern in radiation oncology; it’s also a concern in the millions of X-ray-based fluoroscopy procedures conducted each year during the performance of catheter-based diagnostic and therapeutic interventions. ControlRad Systems Inc. is working to dramatically reduce radiation dose and exposure during fluoroscopy without diminishing the image quality in the region of interest, workflow, or utility of existing X-ray systems.

SoniTrack Systems Inc.

SoniTrack Systems Inc. has integrated robotics and ultrasound to enable precision targeting for radiation therapy. The start-up says its add-on, noninvasive technology has the potential to increase local tumor control rates, reduce healthy tissue toxicity, and reduce overall treatment cost for hospitals; it is initially being evaluated for use in treating cancer in the liver and pancreas, two of the most challenging anatomies to treat with radiation therapy today due to their large motion range during patient breathing.

Nanovi APS

The unavailability of a good fiducial marker for pre-treatment image planning and subsequent image-guided radiotherapy is currently a major obstacle to enhancing radiotherapy standards. Copenhagen, Denmark-based start-up Nanovi APS has developed an injectable, liquid, biomaterials-based tissue marker that promises to improve accuracy in IGRT of several types of cancer, including lung cancer.

Topics

Related Companies

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel